We are living in unprecedented times, and as the response to the COVID-19 pandemic evolves, we wanted to advise you on how we are addressing this situation at PCR Biosystems. 
Our top priorities are the safety and well-being of our employees and the uninterrupted supply of our reagents to customers around the world. We are committed to ensuring researchers and organizations in all markets can access the PCR products and services they need. 

This week we have implemented shift-based working for production, assembly and order fulfillment. We have 3 detached teams working 7 days a week, with 2 fully trained commercial teams in reserve to provide operational support if required. We are working closely with our customers, partners and suppliers, and we are ready to implement further contingency plans if necessary to ensure we continue to meet demand.

Of crucial importance are the needs of our diagnostic partners - including laboratory and hospital customers - in testing for SARS-CoV-2 on a vast scale. To meet these needs and provide supply chain security we have massively increased manufacture of qPCRBIO Probe 1-Step Go and all other critical reagents for rapid and sensitive RT-qPCR. 

We are ready and able to supply you, and we will do all we can to support the scientific effort in responding to COVID-19.

For further information, including large sample packs and technical advice, please get in touch by emailing info@d-markbio.com or call us on 416-297-8220

With best wishes,